PartnershipUpdated on 23 April 2026
Advancing Clinical-Grade Botanical Therapeutics for Endometriosis
About
At Endok.eu, we believe the future of endometriosis (and adenomyosis and other close pathologies) therapy lies in the complexity of nature, validated by the rigor of modern science. We are currently inviting strategic partners to join us in the co-development of our Botanical Drug and Nutraceuticals pipeline.
By moving beyond simple nutraceuticals into the realm of Botanical Drug Development, we are creating standardized, pharmaceutical-grade solutions for chronic pelvic pain and inflammation. We are looking for partners with a shared vision to fund and accelerate these assets through the clinical pipeline.
We are seeking:
-
💰 Capital Partners .
-
🧪 R&D Collaborators with expertise in botanical standardization and CMC.
-
🌍 Strategic Alliances looking to lead the next wave of FemTech innovation.
Join us in bringing the first generation of botanical drugs for endometriosis to the global stage.
Organisation
Similar opportunities
Partnership
BIOTECH: Finding a strategic partner to develop novel psychitric drugs
Dorit Cohen
Founder & CEO at ReSynapse Therapeutics
Nes Ziona, Israel
Project cooperation
Portfolio Company Collaboration: 20/20 OptimEyes Technologies
- Research
- Execution
- Technical
- Biotech, Pharma and Cosmetics
Renaud Jacquemart
CEO at Omnium Global
Burlington, Canada
Partnership
Dorit Cohen
Founder & CEO at ReSynapse Therapeutics
Nes Ziona, Israel